1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Non-Invasive Glucose Monitoring Devices Market: About this market
The non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.
Global Non-Invasive Glucose Monitoring Devices Market: Overview
Increasing demand for non-invasive procedures
The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.
Integration of AI and RADAR technology in glucose monitoring
The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.
Global Non-Invasive Glucose Monitoring Devices Market: Overview
Increasing demand for non-invasive procedures
The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.
Integration of AI and RADAR technology in glucose monitoring
The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
The following companies are recognised as the key players in the global non-invasive glucose monitoring devices market: Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the integration of AI and RADAR technology in glucose monitoring.”
According to the report, one of the major drivers for this market is the increasing demand for non-invasive procedures.
Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with non-invasive glucose monitoring devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the integration of AI and RADAR technology in glucose monitoring.”
According to the report, one of the major drivers for this market is the increasing demand for non-invasive procedures.
Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with non-invasive glucose monitoring devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Integrity Applications Inc.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- Taiwan Biophotonic Co.
Note: Product cover images may vary from those shown
